# FDA WARNING_LETTER - Imprimis Rx LLC - June 30, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/imprimis-rx-llc/0a6f80df-619e-4f5b-9277-f62695f14777

> FDA WARNING_LETTER for Imprimis Rx LLC on June 30, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Imprimis Rx LLC
- Inspection Date: 2022-06-30
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Officers

- [Mark L. Baum](https://www.globalkeysolutions.net/people/mark-l-baum/03c8bd98-912b-43f9-9e41-6ffb00bc3cfe)
- [Program Division Director](https://www.globalkeysolutions.net/people/steven-e-porter/5448db0e-32f0-4e98-8a5f-9f0857373b06)

Company: https://www.globalkeysolutions.net/companies/imprimis-rx-llc/809753a5-6f45-439c-8dbc-21577027b54b

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6